As recorded in multiple studies, SIX1 can be highly expressed in different tumors, including liver cancer, colorectal cancer, gastric cancer, and breast cancer, thus affecting their clinical prognosis [14,17] and signal transduction [18], as well as promoting tumor progression. Here, SIX1 is linked to gastric cancer.